Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Source: CNBC Markets ·
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Read the full story at CNBC Markets
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.